Summit Partners has hired Ricardo Gonzalez as a partner on the firm’s growth products and services team.

Summit Partners, a leading growth-focused investment firm, is pleased to announce the addition of Ricardo Gonzalez as a Partner on the firm’s Growth Products & Services team. Mr. Gonzalez brings more ...

Eli Lilly and Company has invested more than $20 billion in its manufacturing capabilities since 2020 to help meet high ...

The Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV), tracking the healthcare companies under S&P 500, fell about 0.9% ...

PharmStars is accepting applications for its eighth cohort since CEO Naomi Fried founded it four years ago, revolving around ...

Recognizing the increased use of artificial intelligence in the development of new therapies, the U.S. FDA on Monday released ...

The state has spent more than $690 million so far establishing the LEAP Research and Innovation District. Outgoing economic ...

Welcome to a new edition of Spoonful of Technology, where we look at how technology can solve key pharma industry challenges.

Having been in development by Almirall and Eli Lilly and Company for moderate to ... He has been a research fellow at Harvard Medical School, Boston, the University of California, San Francisco ...

BlossomHill Therapeutics, Inc., a clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, today announced ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

Chris Schott, an analyst from J.P. Morgan, maintained the Buy rating on Eli Lilly & Co (LLY – Research Report). The associated price target ...